key: cord-0818042-f9a6ncz1
authors: Shah, Ankit B.; Nabhan, Dustin; Chapman, Robert; Chiampas, George; Drezner, Jonathan; Olin, J. Tod; Taylor, David; Finnoff, Jonathan T.; Baggish, Aaron L.
title: Resumption of Sport at the United States Olympic and Paralympic Training Facilities During the COVID-19 Pandemic
date: 2021-03-12
journal: Sports Health
DOI: 10.1177/19417381211002761
sha: d9b58ca5bedd97e0dd2c23f1a94974d8096abcaf
doc_id: 818042
cord_uid: f9a6ncz1

In this brief report, we describe the safety of reopening US Olympic and Paralympic Training facilities (USOPTFs) during the coronavirus disease 2019 (COVID-19) pandemic from July 2020 through October 2020. We evaluated the prevalence of COVID-19 infection at the time of reentry and cardiopulmonary sequelae of COVID-19 in elite athletes. All athletes returning to a USOPTF were required to go through a reentry protocol consisting of an electronic health history, a 6-day quarantine including twice-daily symptom surveys, COVID-19 polymerase chain reaction and antibody testing, physical examination, 12-lead electrocardiogram, high-sensitivity cardiac troponin I, and pulmonary function testing. Athletes with current or prior COVID-19 infection also underwent an echocardiogram, cardiology consultation, and additional testing as indicated. All athletes followed rigorous infection prevention measures and minimized contact with the outside community following reentry. At the time of this report, 301 athletes completed the reentry protocol among which 14 (4.7%) tested positive for active (positive polymerase chain reaction test, n = 3) or prior (positive antibody test, n = 11) COVID-19 infection. During the study period, this cohort accrued 14,916 days living and training at USOPTFs. Only one (0.3%) athlete was subsequently diagnosed with a new COVID-19 infection. No cardiopulmonary pathology attributable to COVID-19 was detected. Our findings suggest that residential elite athlete training facilities can successfully resume activity during the COVID-19 pandemic when strict reentry and infection prevention measures are followed. Dissemination of our reentry quarantine and screening protocols with COVID-19 mitigation measures may assist the global sports and medical community develop best practices for reopening of similar training centers.

closure, the USOPTFs reopened in July 2020. Here we report our medical protocols and early results of this experience.

The USOPTFs' COVID-19 pandemic "return-to-training" protocol is shown in Figure 1 . Both on-site and off-site athletes completed the same protocol. Prior to arrival at an USOPTF, athletes completed an electronic health history including questions about prior COVID-19 exposure, documented COVID-19 infection, and travel in the past 14 days. This survey was designed to identify athletes with prior or current COVID-19 infection so appropriate measures can be taken prior to their travel to an USOPTF. On arrival, athletes (no other personnel) begin a 6-day quarantine during which they are required to fill out twice-daily symptom surveys. The 6-day quarantine was recommended by our Infectious Disease Advisory Group, composed of public health and infectious disease experts, after weighing the risks and benefits of various quarantine durations. During the quarantine period, athletes were provided with a personalized training program by strength and conditioning personnel that they could complete in their rooms. Equipment, such as dumbbells, stretch bands, and cardiovascular equipment (eg, bicycle trainer), were provided based on the athlete's needs. On days 4 and 5 of the quarantine process, athletes receive a saliva-based COVID-19 polymerase chain reaction (PCR) test (Spectrum Solutions, LLC), and on day 5 they receive a COVID-19 antibody test (Premier Biotech, Inc). The tests were completed by medical personnel wearing personal protective equipment (ie, N95 mask, eye protection, gown, and gloves) in the athlete's room. Athletes with a positive PCR are placed in isolation following Centers for Disease Control and Prevention guidelines, 2 after which they complete the evaluation summarized below. After completing the reentry quarantine, all athletes undergo a routine elite athlete preparticipation evaluation, 4,5 which at the USOPTF includes a resting 12-lead electrocardiogram (ECG) 10 and pulmonary function testing. 12 A blood assay for high-sensitivity cardiac troponin I (hs-cTnI) was also performed on all athletes postquarantine. Since data are limited on hs-cTnI levels in Olympic and Paralympic athletes, it was determined that obtaining a hs-cTnI on all of our athletes postquarantine would improve our ability to interpret test results. Athletes with a history of COVID-19 infection (positive PCR or antibody) also undergo a transthoracic echocardiogram and cardiology consultation. Additional tests (eg, cardiac magnetic resonance imaging [cMRI]) and consultations are performed as indicated. In the absence of cardiopulmonary pathology, athletes are permitted to resume training. After completing the reentry protocol, athletes are required to follow rigorous infection prevention measures ( Table 1 ). Publication of de-identified data derived from this protocol was approved by the Mass General Brigham human subjects research committee. 

Protocols (Table 1) No Physician note confirming asymptomaƟc and completed CDC Guideline-Based IsolaƟon or COVID-19 PCR (-) 

At the time of this report, 301 athletes (43% female) completed this protocol and 14 (4.7%) tested positive for active (positive PCR test, n = 3) or prior (positive antibody test, n = 11) COVID-19 infection. Two of the athletes with positive PCR tests and 2 of the athletes with positive antibody tests lived on-site, while one athlete with a positive PCR test and 9 athletes with positive antibody tests lived off-site. Each of these athletes were asymptomatic or had mild symptom burden during infection. returning to organized training was lower than those reported in the public media among US collegiate and professional team sport athletes. 3 This may be explained by the fact that the majority of our cohort are athletes participating in individual sporting disciplines, who were able to train in isolation and/or with effective social distancing prior to USOPTF arrival. Second, while our sample size was small, the mild severity COVID-19 infection among young, previously healthy athletes in this cohort did not result in clinically relevant cardiovascular disease. Third, our COVID-19 risk mitigation strategy effectively prevented new COVID-19 infection among athletes. Finally, we identified no adverse events during the observed training period among athletes with prior COVID-19 infection.

Internationally, many resident sport training facilities similar to the USOPTFs will resume activity as competitions, including the 2021 Olympic Games, move forward. Dissemination of our entry screening protocols, quarantine measures, training protocol modifications, and risk mitigation strategies that have successfully prevented on-site COVID-19 outbreaks may assist the global sports and medical community with their planning. However, we acknowledge that our data are subject to several limitations. In accordance with published practice guidelines, 6 we did not perform cMRI on our athletes with active or prior infection as all presented asymptomatic or with mild symptom burden. We may therefore have failed to detect subtle cardiac changes attributable to prior COVID-19 infection. Prospective acquisition of cMRI data coupled with a control group and clinical follow-up will be needed to determine the optimal use of this imaging modality during the COVID-19 pandemic. Additionally, our follow-up of 14,916 athlete days may not have been sufficient to capture possible adverse events. Ongoing surveillance with a commitment to disseminate additional findings is warranted. Following reentry, only athletes who developed signs and symptoms of COVID-19 were retested for infection. Although new asymptomatic cases may have been missed, an undetected outbreak in our closely monitored population is unlikely. Furthermore, ongoing COVID-19 screening adds significant cost with uncertain benefit to the COVID-19 mitigation program, making this measure unattainable for many organizations providing closed residential training. Studies replicating our results in other training settings are needed. Finally, while many of the infection prevention measures implemented as part of this protocol are broadly applicable to most settings, some of the measures taken (eg, quarantine and testing procedures) may be challenging for those with less resources such as recreational leagues and high schools.

conclusion Data characterizing the USOPTFs' early experience suggest that residential elite athlete training facilities in a controlled environment can successfully resume activity during the COVID-19 pandemic. The continued health and wellness of athletes will require a multitiered strategy that includes effective preparticipation screening, isolation of infected athletes, modified training protocols, and limited community exposure.

A: consistent, good-quality patient-oriented evidence B: inconsistent or limited-quality patient-oriented evidence C: consensus, disease-oriented evidence, usual practice, expert opinion, or case series Clinical Recommendation

Our findings suggest that residential elite athlete training facilities can successfully resume activity during the COVID-19 pandemic when strict reentry and institutional infection prevention measures are followed.

Resurgence of sport in the wake of COVID-19: cardiac considerations in competitive athletes

When you can be around others after you had or likely had COVID-19

A lot of athletes seem to have the coronavirus. Here are some reasons. The New York Times

Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology

Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task force 2: Preparticipation screening for cardiovascular disease in competitive athletes: a scientific statement from the American Heart Association and American College of Cardiology

A game plan for the resumption of sport and exercise after coronavirus disease 2019 (COVID-19) infection

Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)

Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection

Return to sports after COVID-19 infection

International recommendations for electrocardiographic interpretation in athletes

Return to sports after COVID-19: a position paper from the Dutch Sports Cardiology Section of the Netherlands Society of Cardiology

Cardiorespiratory considerations for returnto-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians

For article reuse guidelines, please visit SAGE